Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
People with X-linked hypophosphatemia (XLH) frequently experience pain, stiffness, and fatigue, which have a significant impact on their physical functioning, mental health, and daily lives, a study reports. They ... Read more
One-year treatment with Crysvita (burosumab) led to the normalization of phosphate levels in children with X-linked hypophosphatemia (XLH) and helped improve their growth, a small real-world study shows. The ... Read more